BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 30448416)

  • 1. Benzofuran derivatives and their anti-tubercular, anti-bacterial activities.
    Xu Z; Zhao S; Lv Z; Feng L; Wang Y; Zhang F; Bai L; Deng J
    Eur J Med Chem; 2019 Jan; 162():266-276. PubMed ID: 30448416
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Benzofuran-isatin-imine hybrids tethered via different length alkyl linkers: Design, synthesis and in vitro evaluation of anti-tubercular and anti-bacterial activities as well as cytotoxicity.
    Gao F; Wang T; Gao M; Zhang X; Liu Z; Zhao S; Lv Z; Xiao J
    Eur J Med Chem; 2019 Mar; 165():323-331. PubMed ID: 30690301
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recent advances of tetrazole derivatives as potential anti-tubercular and anti-malarial agents.
    Gao C; Chang L; Xu Z; Yan XF; Ding C; Zhao F; Wu X; Feng LS
    Eur J Med Chem; 2019 Feb; 163():404-412. PubMed ID: 30530192
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recent advances of imidazole-containing derivatives as anti-tubercular agents.
    Fan YL; Jin XH; Huang ZP; Yu HF; Zeng ZG; Gao T; Feng LS
    Eur J Med Chem; 2018 Apr; 150():347-365. PubMed ID: 29544148
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Design, synthesis, in vitro and in silico studies of 2, 3-diaryl benzofuran derivatives as antitubercular agents.
    Bhukya B; Shukla A; Chaturvedi V; Trivedi P; Kumar S; Khan F; Negi AS; Srivastava SK
    Bioorg Chem; 2020 Jun; 99():103784. PubMed ID: 32361184
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An update on benzofuran inhibitors: a patent review.
    Dawood KM
    Expert Opin Ther Pat; 2019 Nov; 29(11):841-870. PubMed ID: 31560232
    [No Abstract]   [Full Text] [Related]  

  • 7. A review on antioxidant potential of bioactive heterocycle benzofuran: Natural and synthetic derivatives.
    Chand K; Rajeshwari ; Hiremathad A; Singh M; Santos MA; Keri RS
    Pharmacol Rep; 2017 Apr; 69(2):281-295. PubMed ID: 28171830
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fluoroquinolone-isatin hybrids and their biological activities.
    Xu Z; Zhao SJ; Lv ZS; Gao F; Wang Y; Zhang F; Bai L; Deng JL
    Eur J Med Chem; 2019 Jan; 162():396-406. PubMed ID: 30453247
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Therapeutic Potential of Naturally Occurring Benzofuran Derivatives and Hybrids of Benzofurans with other Pharmacophores as Antibacterial Agents.
    Xu Z; Xu D; Zhou W; Zhang X
    Curr Top Med Chem; 2022; 22(1):64-82. PubMed ID: 34809548
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recent advances of pyrazole-containing derivatives as anti-tubercular agents.
    Xu Z; Gao C; Ren QC; Song XF; Feng LS; Lv ZS
    Eur J Med Chem; 2017 Oct; 139():429-440. PubMed ID: 28818767
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Design, synthesis and anti-mycobacterial activity evaluation of benzofuran-isatin hybrids.
    Gao F; Yang H; Lu T; Chen Z; Ma L; Xu Z; Schaffer P; Lu G
    Eur J Med Chem; 2018 Nov; 159():277-281. PubMed ID: 30296686
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recent developments of coumarin-containing derivatives and their anti-tubercular activity.
    Hu YQ; Xu Z; Zhang S; Wu X; Ding JW; Lv ZS; Feng LS
    Eur J Med Chem; 2017 Aug; 136():122-130. PubMed ID: 28494250
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Benzofuran derivatives: a patent review.
    Dawood KM
    Expert Opin Ther Pat; 2013 Sep; 23(9):1133-56. PubMed ID: 23683135
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Isatin derivatives and their anti-bacterial activities.
    Guo H
    Eur J Med Chem; 2019 Feb; 164():678-688. PubMed ID: 30654239
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Triazole derivatives and their anti-tubercular activity.
    Zhang S; Xu Z; Gao C; Ren QC; Chang L; Lv ZS; Feng LS
    Eur J Med Chem; 2017 Sep; 138():501-513. PubMed ID: 28692915
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bioactive Benzofuran derivatives: A review.
    Khanam H; Shamsuzzaman
    Eur J Med Chem; 2015 Jun; 97():483-504. PubMed ID: 25482554
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Isoniazid derivatives and their anti-tubercular activity.
    Hu YQ; Zhang S; Zhao F; Gao C; Feng LS; Lv ZS; Xu Z; Wu X
    Eur J Med Chem; 2017 Jun; 133():255-267. PubMed ID: 28390957
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis and evaluation of anti-tubercular and antibacterial activities of new 4-(2,6-dichlorobenzyloxy)phenyl thiazole, oxazole and imidazole derivatives. Part 2.
    Lu X; Liu X; Wan B; Franzblau SG; Chen L; Zhou C; You Q
    Eur J Med Chem; 2012 Mar; 49():164-71. PubMed ID: 22264895
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fluoroquinolone derivatives and their anti-tubercular activities.
    Fan YL; Wu JB; Cheng XW; Zhang FZ; Feng LS
    Eur J Med Chem; 2018 Feb; 146():554-563. PubMed ID: 29407980
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Design, synthesis, and antitubercular evaluation of novel series of 3-benzofuran-5-aryl-1-pyrazolyl-pyridylmethanone and 3-benzofuran-5-aryl-1-pyrazolylcarbonyl-4-oxo-naphthyridin analogs.
    Manna K; Agrawal YK
    Eur J Med Chem; 2010 Sep; 45(9):3831-9. PubMed ID: 20576327
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.